This study aimed to investigate how septicaemia, non-septicaemia infection and the disease itself are associated with disease activity and mortality in inpatients with systemic lupus erythematosus (SLE) in Taiwan.
Methods
We retrospectively reviewed 1115 patients and enrolled 427 with SLE admitted for lupus flare-ups and co-morbidities. Disease activity and infection type/site were recorded and categorized according to the causes of admission and mortality into three categories, of which two were specified as follows: (a) septicaemia admissions, non-septicaemia admissions; and (b) septicaemia mortality, non-septicaemia infection mortality and non-infection mortality. The relationships between lupus flare-ups and mortality in different groups were analysed using an unpaired t-test, Mann–Whitney U-test and logistic regression.
Results
Septicaemia was the major cause of mortality in SLE inpatients. There were 98 (22.95%) mortality patients among all 427 SLE patients. The septicaemia admissions had higher disease activity (SLE Disease Activity Index 2000 = 13.00 ± 7.98) than the non-septicaemia admissions (9.77 ± 5.72; p < 0.01). The mean current SLEDAI score of the septicaemia mortality group (14.91 ± 8.01) was higher than that of the non-septicaemia infection mortality group (10.05 ± 5.75; p = 0.02), in spite of the similar mean earlier SLEDAI score. The risk of mortality in the septicaemia mortality group due to previous septicaemia admissions was 13.2 times (odds ratio) higher than in the non-septicaemia infection mortality group and 15.6 times higher than in the non-infection mortality group.
Conclusion
Septicaemia relates to increased lupus disease activity and is associated with a greater risk of mortality in the SLE patients than other causes of admission. Fewer previous septicaemia admissions decrease the risk of septicaemia mortality.
KamenDL. Environmental influences on systemic lupus erythematosus expression. Rheum Dis Clin North Am2014; 40: 401–412, vii.
2.
LehmannPHomeyB. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmun Rev2009; 8: 456–461.
3.
PiroozmandAHaddad KashaniHZamaniB. Correlation between Epstein–Barr virus infection and disease activity of systemic lupus erythematosus: a cross-sectional study. Asian Pac J Cancer Prev2017; 18: 523–527.
4.
WardMMPyunEStudenskiS. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med1996; 156: 1337–1344.
5.
Abu-ShakraMUrowitzMBGladmanDDGoughJ. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol1995; 22: 1265–1270.
6.
RubinLAUrowitzMBGladmanDD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. QJM1985; 55: 87–98.
7.
Abu-ShakraMUrowitzMBGladmanDDGoughJ. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol1995; 22: 1259–1264.
8.
TragerJWardMM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol2001; 13: 345–351.
9.
MossKEIoannouYSultanSMHaqIIsenbergDA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis2002; 61: 409–413.
10.
BjornadalLYinLGranathFKlareskogLEkbomA. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol2004; 31: 713–719.
11.
CartellaSCavazzanaICeribelliAInverardiFTincaniAFranceschiniF. Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic lupus erythematosus. Autoimmunity2013; 46: 363–368.
12.
BernatskySBoivinJFJosephL, et al.Mortality in systemic lupus erythematosus. Arthritis Rheum2006; 54: 2550–2557.
13.
Urowitz MB, Su J, Gladman DD. Atherosclerotic vascular events in systemic lupus erythematosus: an evolving story. J Rheumatol. Epub ahead of print 1 February 2019. DOI :10.3899/jrheum.180986.
14.
Zandman-GoddardGShoenfeldY. SLE and infections. Clin Rev Allergy Immunol2003; 25: 29–40.
15.
PetriM. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am1998; 24: 423–456.
16.
WangZWangYZhuR, et al.Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore)2015; 94: e794–e794.
17.
GladmanDDHussainFIbanezDUrowitzMB. The nature and outcome of infection in systemic lupus erythematosus. Lupus2002; 11: 234–239.
18.
GoldblattFChambersSRahmanAIsenbergDA. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus2009; 18: 682–689.
19.
LeeJDhillonNPopeJ. All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford)2013; 52: 905–909.
20.
FeldmanCHHirakiLTWinkelmayerWC, et al.Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol2015; 67: 1577–1585.
21.
Gonzalez-EchavarriCCapdevilaOEspinosaG, et al.Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort. Lupus2018; 27: 2253–2261.
22.
Ruiz-IrastorzaGOlivaresNRuiz-ArruzaIMartinez-BerriotxoaAEgurbideMVAguirreC. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther2009; 11: R109–R109.
23.
CerveraRKhamashtaMAFontJ, et al.Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore)2003; 82: 299–308.
24.
ZhouWJYangCD. The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients. Lupus2009; 18: 807–812.
25.
Al-RayesHAl-SwailemRArfinMSobkiSRizviSTariqM. Systemic lupus erythematosus and infections: a retrospective study in Saudis. Lupus2007; 16: 755–763.
26.
NivedOSturfeltGWollheimF. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. QJM1985; 55: 271–287.
27.
Hidalgo-TenorioCJimenez-AlonsoJDe Dios LunaJTalladaMMartinez-BrocalASabioJM. Urinary tract infections and lupus erythematosus. Ann Rheum Dis2004; 63: 431–437.
28.
CuchacovichRGedaliaA. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am2009; 35: 75–93.
29.
ChenHSTsaiWPLeuHSHoHHLiouLB. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology (Oxford)2007; 46: 539–544.
30.
TsaiWPChenMHLeeMHYuKHWuMWLiouLB. Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan. Rheumatol Int2012; 32: 2901–2908.
31.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
YeeCSFarewellVTIsenbergDA, et al.The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford)2011; 50: 982–988.
34.
DubulaTModyGM. Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus. Clin Rheumatol2015; 34: 479–488.
35.
BoschXGuilabertAPallaresL, et al.Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus2006; 15: 584–589.
36.
WardMMPyunEStudenskiS. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum1995; 38: 1492–1499.
37.
NoelVLortholaryOCasassusP, et al.Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis2001; 60: 1141–1144.
38.
JanwityanuchitSTotemchokchyakarnKKrachangwongchaiKVatanasukM. Infection in systemic lupus erythematosus. J Med Assoc Thai1993; 76: 542–548.
39.
Merayo-ChalicoJGomez-MartinDPineirua-MenendezASantana-De AndaKAlcocer-VarelaJ. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. QJM2013; 106: 451–457.
40.
Navarro-ZarzaJEAlvarez-HernandezECasasola-VargasJCEstrada-CastroEBurgos-VargasR. Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus2010; 19: 43–48.
41.
JeongSJChoiHLeeHS, et al.Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Dis2009; 41: 268–274.
42.
SchusterHP. [Infection as a cause of multiple organ failure. Definition, pathophysiology and diagnostic parameters]. Anasth Intensivther Notfallmed1989; 24: 206–211.
